$CRSP
CRISPR Therapeutics AG
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$57.50
▲+3.73%+$2.07
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCRISPR Therapeutics AG
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is CRSP up today? It is at $57.50 (+3.73%), and our scanner flagged it 127 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CRSP spikes, and full due diligence on CRSP — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CRSP 127 times in the last 30 days. Create a free account to track $CRSP, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
CRSP is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 7 unusual-volume and momentum alerts on CRSP today, peaking at 18.5x its normal volume.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kasinger James R. Officer | Sold (automatic/other) | -10K 0.01% of company | sold 9.9% | 95K | $626K at $60.24 | Sep 22, 26 |
Kasinger James R. Officer | Other | 10K 0.01% of company | added 11% | 105K | $142K at $13.62 | Sep 22, 26 |
Behbahani Ali Director | Sold (automatic/other) | -14K 0.01% of company | sold 45% | 17K | $781K at $57.09 | Sep 17, 26 |
Behbahani Ali Director | Other | 30K 0.03% of company | added 100% | 30K | $420K at $14.00 | Sep 17, 26 |
Prasad Raju Officer | Sold (automatic/other) | -750 | sold 4.8% | 15K | n/a | Aug 7, 26 |
Patel Naimish Officer | Sold (automatic/other) | -4K | sold 16% | 19K | $211K at $55.62 | May 29, 26 |
Patel Naimish Officer | Other | 10K 0.01% of company | added 76% | 23K | n/a | May 28, 26 |
Prasad Raju Officer | Sold (automatic/other) | -4K | sold 19% | 16K | $173K at $46.78 | Mar 23, 26 |
Kulkarni Samarth Officer | Sold (automatic/other) | -10K 0.01% of company | sold 3.8% | 256K | $469K at $46.78 | Mar 23, 26 |
Kasinger James R. Officer | Sold (automatic/other) | -3K | sold 3.3% | 94K | $149K at $46.78 | Mar 23, 26 |
Prasad Raju Officer | Other | 6K | added 48% | 19K | n/a | Mar 20, 26 |
Kulkarni Samarth Officer | Other | 20K 0.02% of company | added 8.0% | 266K | n/a | Mar 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
CRSP is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 7 unusual-volume and momentum alerts on CRSP today, peaking at 18.5x its normal volume.
CRSP last traded at $57.50, up 3.73% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
CRISPR Therapeutics AG (CRSP) is next expected to report earnings on Monday, November 9, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CRSP Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CRSP 127 times in the last 30 days.
CRSP (CRISPR Therapeutics AG) trades on XNAS, with a market cap of about $5.36B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CRSP for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CRSP discussion
Sign in to ask a question or join the discussion.